Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children

Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin, Sébastien, Lallemant, Marc, Garcia-Prats, Anthony, Lewis, Linda, Watkins, Melynda, Giaquinto, Carlo, Valentin, Marie, Penazzato, Martina, Reeder, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658058/
https://www.ncbi.nlm.nih.gov/pubmed/34784302
http://dx.doi.org/10.1097/INF.0000000000003331
_version_ 1784612641928380416
author Morin, Sébastien
Lallemant, Marc
Garcia-Prats, Anthony
Lewis, Linda
Watkins, Melynda
Giaquinto, Carlo
Valentin, Marie
Penazzato, Martina
Reeder, John C.
author_facet Morin, Sébastien
Lallemant, Marc
Garcia-Prats, Anthony
Lewis, Linda
Watkins, Melynda
Giaquinto, Carlo
Valentin, Marie
Penazzato, Martina
Reeder, John C.
author_sort Morin, Sébastien
collection PubMed
description Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to collectively accelerate pediatric COVID-19 therapeutic research and development, based on the experience of the Global Accelerator for Paediatric Formulations.
format Online
Article
Text
id pubmed-8658058
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86580582021-12-10 Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children Morin, Sébastien Lallemant, Marc Garcia-Prats, Anthony Lewis, Linda Watkins, Melynda Giaquinto, Carlo Valentin, Marie Penazzato, Martina Reeder, John C. Pediatr Infect Dis J Commentary Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to collectively accelerate pediatric COVID-19 therapeutic research and development, based on the experience of the Global Accelerator for Paediatric Formulations. Lippincott Williams & Wilkins 2021-11-26 2022-01 /pmc/articles/PMC8658058/ /pubmed/34784302 http://dx.doi.org/10.1097/INF.0000000000003331 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Morin, Sébastien
Lallemant, Marc
Garcia-Prats, Anthony
Lewis, Linda
Watkins, Melynda
Giaquinto, Carlo
Valentin, Marie
Penazzato, Martina
Reeder, John C.
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
title Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
title_full Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
title_fullStr Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
title_full_unstemmed Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
title_short Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
title_sort pediatric covid-19 therapeutics: seizing the right research and development opportunities to accelerate access for children
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658058/
https://www.ncbi.nlm.nih.gov/pubmed/34784302
http://dx.doi.org/10.1097/INF.0000000000003331
work_keys_str_mv AT morinsebastien pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT lallemantmarc pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT garciapratsanthony pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT lewislinda pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT watkinsmelynda pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT giaquintocarlo pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT valentinmarie pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT penazzatomartina pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren
AT reederjohnc pediatriccovid19therapeuticsseizingtherightresearchanddevelopmentopportunitiestoaccelerateaccessforchildren

Ejemplares similares